Tech Company Financing Transactions
Prenosis Funding Round
Prenosis closed a $40 million funding round on 1/29/2026. Investors included PACE Healthcare Capital, Biomedical Advanced Research and Development Authority and Global Health Investment Corporation.
Transaction Overview
Company Name
Announced On
1/29/2026
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$40,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Chicago, IL Undisclosed
USA
Chicago, IL Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Prenosis, Inc. is a biology-based technology company redefining the standard of care for critical conditions. We believe healthcare should not follow a one-size-fits-all model. Instead, our mission is to tailor healthcare to each patient's biology through the creation and delivery of integrated diagnostics and therapeutics. We use deep data and AI to build tools that augment clinical diagnosis of critical conditions based on each patient's unique biological profile.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bobby Reddy
Browse more venture capital transactions:
Prev: 1/29/2026: Automata venture capital transaction
Next: 1/29/2026: Doppler venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document tech company VC transactions. VC investment data records reported here are derived from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs